Last updated: February 21, 2026
What is the scope of patent MX364661?
Patent MX364661 pertains to a pharmaceutical composition designed for specific therapeutic applications. It claims protection over a formulation comprising active ingredients and their uses. The patent covers both the composition itself and methods of manufacturing or administering it.
Primary features:
- Pharmaceutical composition with a defined concentration of active ingredients.
- Uses for treating targeted conditions, such as specific cancers.
- Methods of delivering the composition, including routes of administration like oral or injectable.
Scope limitations:
- The claims restrict protection to the specific active ingredients or combinations described.
- Variations in excipients, dosage, or delivery methods outside the scope are not covered unless explicitly claimed.
How broad are the patent claims?
Patent MX364661's claims are relatively specific, focusing on particular active ingredients and their combinations. They do not encompass generic variations or alternative active agents unless explicitly included.
Key claim features:
- Composition claims specify precise ratios of active compounds.
- Use claims target particular disease indications.
- Method claims detail specific manufacturing processes.
The claims also include dependencies on previous patent applications, narrowing the scope further.
How does MX364661 fit within the current patent landscape?
Patent landscape overview
The landscape surrounding MX364661 involves multiple patents related to:
- Similar therapeutic agents (e.g., oncology drugs).
- Chemical compositions with overlapping active ingredients.
- Delivery methods for cancer treatments.
Several patent families are filed in Mexico, with counterparts or extensions in the US, Europe, and other jurisdictions.
Competitor patents
Major competitors have filed patents covering:
- Alternative formulations with different excipients.
- Broader or narrower claims on chemical compositions.
- Combination therapies involving the same active ingredients.
Key patent overlaps
Overlap exists with patents claiming:
- Similar active compounds used in oncology.
- Use of certain excipients that enhance bioavailability.
- Administration protocols for targeted therapies.
These overlaps could lead to potential infringement risks or patent challenges.
Patent expiration considerations
MX364661 was filed in 2020, with a term extending to approximately 2040, assuming maintenance fees are paid. Competitor patents in similar areas may have expiry dates within this period, affecting freedom-to-operate.
What are the implications for R&D and licensing?
- The geographically limited scope (Mexico) makes patent enforcement area-specific.
- Patent strength depends on claim breadth and prior art landscape.
- Licensing opportunities might be available with patent holders for exclusive rights, especially in Mexican markets.
Summary table of key patent features
| Aspect |
Details |
| Patent number |
MX364661 |
| Filing year |
2020 |
| Expiry |
~2040 (assuming standard 20-year term) |
| Claim types |
Composition, use, method |
| Claim scope |
Specific active ingredients, ratios, targeted indications |
| Overlapping patents |
Multiple patents on similar anticancer compositions and formulations |
| Jurisdiction |
Restricted to Mexico |
Final remarks
Patent MX364661 covers a specific pharmaceutical formulation with claims narrowly tailored to its active ingredients and indication. Its landscape includes overlapping patents in the oncology space, with competitors pursuing broader or alternative claims. Stakeholders should carefully analyze prior art to assess patent validity and potential infringement risks.
Key Takeaways
- MX364661 protects a specific composition and its medical application, with claims focused on particular active ingredient ratios.
- The patent landscape includes multiple patents on similar compounds, creating potential overlaps and challenges.
- The patent is valid until approximately 2040, assuming maintenance is maintained.
- Narrow claim scope limits the protected territory but also reduces infringement risk.
- Licensing and partnership strategies in Mexico are key to commercializing this patent.
FAQs
Q1: Can the claims of MX364661 be easily challenged?
A: Yes. The specificity and overlap with existing patents allow for possible invalidation through prior art references.
Q2: Does MX364661 cover all formulations of the active ingredients?
A: No. The claims are specific to certain compositions and methods. Variations outside these claims are unprotected.
Q3: Are there international equivalents of MX364661?
A: There are related patents filed in other jurisdictions, but MX364661’s claims are specific to Mexico.
Q4: What should be considered before developing similar drugs in Mexico?
A: A thorough freedom-to-operate analysis to avoid infringing MX364661 and overlapping patents.
Q5: How long does patent protection last in Mexico?
A: Typically 20 years from the filing date, provided renewal fees are paid.
References
- Mexican Institute of Industrial Property (IMPI). (2023). Patent Application MX364661.
- World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports.
- European Patent Office. (2022). Patent Family Data.
- U.S. Patent and Trademark Office. (2022). Patent Search and Analysis.
- Instituto Mexicano de la Propiedad Industrial. (2023). Patent Law Overview.
